261 related articles for article (PubMed ID: 1384962)
61. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
[TBL] [Abstract][Full Text] [Related]
62. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products.
Braun T; Bober E; Buschhausen-Denker G; Kohtz S; Grzeschik KH; Arnold HH
EMBO J; 1989 Dec; 8(12):3617-25. PubMed ID: 2583111
[TBL] [Abstract][Full Text] [Related]
63. Caveolin-3 is a sensitive and specific marker for rhabdomyosarcoma.
Fine SW; Lisanti MP; Argani P; Li M
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):231-6. PubMed ID: 16082247
[TBL] [Abstract][Full Text] [Related]
64. Two distinct Xenopus genes with homology to MyoD1 are expressed before somite formation in early embryogenesis.
Scales JB; Olson EN; Perry M
Mol Cell Biol; 1990 Apr; 10(4):1516-24. PubMed ID: 1690844
[TBL] [Abstract][Full Text] [Related]
65. The four human muscle regulatory helix-loop-helix proteins Myf3-Myf6 exhibit similar hetero-dimerization and DNA binding properties.
Braun T; Arnold HH
Nucleic Acids Res; 1991 Oct; 19(20):5645-51. PubMed ID: 1945842
[TBL] [Abstract][Full Text] [Related]
66. Nuclear localization of antigens detected by a monoclonal antibody against a synthetic peptide of rfp finger protein.
Kikuchi T; Takahashi M; Ueda R; Ohba M; Seito T; Hiai H; Nakashima I; Takahashi T
Hybridoma; 1990 Apr; 9(2):189-200. PubMed ID: 2112113
[TBL] [Abstract][Full Text] [Related]
67. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.
Anand G; Shapiro DN; Dickman PS; Prochownik EV
J Clin Invest; 1994 Jan; 93(1):5-9. PubMed ID: 8282820
[TBL] [Abstract][Full Text] [Related]
68. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.
Tapscott SJ; Davis RL; Thayer MJ; Cheng PF; Weintraub H; Lassar AB
Science; 1988 Oct; 242(4877):405-11. PubMed ID: 3175662
[TBL] [Abstract][Full Text] [Related]
69. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products.
Huff JP; Roos G; Peebles CL; Houghten R; Sullivan KF; Tan EM
J Exp Med; 1990 Aug; 172(2):419-29. PubMed ID: 1695666
[TBL] [Abstract][Full Text] [Related]
70. Epitope mapping of bovine retinal S-antigen with monoclonal antibodies.
Knospe V; Donoso LA; Banga JP; Yue S; Kasp E; Gregerson DS
Curr Eye Res; 1988 Nov; 7(11):1137-47. PubMed ID: 2468451
[TBL] [Abstract][Full Text] [Related]
71. Monoclonal antibody NM11 recognizes a C-terminal epitope shared by p300 and CBP.
Dallas PB; Yaciuk P; Moran E
Hybridoma; 1997 Jun; 16(3):273-5. PubMed ID: 9219037
[TBL] [Abstract][Full Text] [Related]
72. Regional localization of porcine MYOD1, MYF5, LEP, UCP3 and LCN1 genes.
Cepica S; Yerle M; Stratil A; Schröffel J; Redl B
Anim Genet; 1999 Dec; 30(6):476-8. PubMed ID: 10612255
[No Abstract] [Full Text] [Related]
73. Specificity of antibodies: unexpected cross-reactivity of antibodies directed against the excitatory amino acid transporter 3 (EAAT3).
Holmseth S; Dehnes Y; Bjørnsen LP; Boulland JL; Furness DN; Bergles D; Danbolt NC
Neuroscience; 2005; 136(3):649-60. PubMed ID: 16344142
[TBL] [Abstract][Full Text] [Related]
74. Mapping epitope specificities of monoclonal antibodies to thyroid peroxidase using recombinant antigen preparations.
Ewins DL; Barnett PS; Tomlinson RW; McGregor AM; Banga JP
Autoimmunity; 1992; 11(3):141-9. PubMed ID: 1373960
[TBL] [Abstract][Full Text] [Related]
75. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.
Lassar AB; Thayer MJ; Overell RW; Weintraub H
Cell; 1989 Aug; 58(4):659-67. PubMed ID: 2548731
[TBL] [Abstract][Full Text] [Related]
76. Assignment of the porcine loci for MYOD1 to chromosome 2 and MYF5 to chromosome 5.
Soumillion A; Rettenberger G; Vergouwe MN; Erkens JH; Lenstra JA; te Pas MF
Anim Genet; 1997 Feb; 28(1):37-8. PubMed ID: 9124704
[TBL] [Abstract][Full Text] [Related]
77. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A
J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905
[TBL] [Abstract][Full Text] [Related]
78. MyoD1 and myogenin expression in human neoplasia: a review and update.
Folpe AL
Adv Anat Pathol; 2002 May; 9(3):198-203. PubMed ID: 11981115
[TBL] [Abstract][Full Text] [Related]
79. The mouse mismatch repair protein, MSH3, is a nucleoplasmic protein that aggregates into denser nuclear bodies under conditions of stress.
Holt I; Thanh Lam L; Tomé S; Wansink DG; Te Riele H; Gourdon G; Morris GE
J Cell Biochem; 2011 Jun; 112(6):1612-21. PubMed ID: 21344488
[TBL] [Abstract][Full Text] [Related]
80. Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs.
Duclert A; Piette J; Changeux JP
Neuroreport; 1991 Jan; 2(1):25-8. PubMed ID: 1768845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
